Diabetic amyotrophy in a teenage boy.
نویسندگان
چکیده
CASE REPORT. A 16-year old boy was admitted following an overdose of 48 tablets of diclofenac 100 mg, 20 tablets of codeine phosphate 30 mg and 40 tablets of paracetamol 500 mg. He was alert and felt well on admission. General examination was normal. His serum paracetamol level on arrival was 34 mg/I, which did not justify treatment with acetyl cysteine. Serum sodium, potassium and urea were normal. He was treated conservatively and observed overnight. On further questioning the patient revealed that the reason for his overdose was increasing clumsiness in his legs over the preceding six months which had halted a promising athletic career and had led to him being the focus of teasing at school. His home situation seemed to be supportive and caring, and no other cause for his attempted suicide was apparent.
منابع مشابه
AAEM case report #13: diabetic amyotrophy.
A case fulfilling the criteria for the diagnosis of diabetic amyotrophy is reported. Based on the clinical and electrodiagnostic features, it is concluded that diabetic amyotrophy is a recognizable clinical entity that can be differentiated from other diabetic neuropathies. The site of the lesion and the pathogenesis in diabetic amyotrophy remain controversial. The course of the illness is vari...
متن کاملCASE REPORT An unusual presentation of diabetic amyotrophy: myoclonus
To cite: Zaidi SA, Chhetri SK, Lekwuwa G, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2012008245 SUMMARY Diabetic amyotrophy is a distinctive form of diabetic neuropathy. It is characterised by a weakness and wasting of proximal muscles of the lower limbs with associated pain. We report a case of an elderly patient with unusual presentation of diabetic ...
متن کاملHuman immunoglobulin for diabetic amyotrophy--a promising prospect?
Diabetic neuropathies are universally recognised and cause significant morbidity. At present improving glycaemic control is the only recognised treatment. A man with type 2 diabetes presented with disabling asymmetric lower limb proximal neuropathy. Rapid clinical, functional, and electrical improvement followed treatment with intravenous immunoglobulin. The aetiology of diabetic amyotrophy rem...
متن کاملCASE REPORTS Human immunoglobulin for diabetic amyotrophy—a promising prospect?
Diabetic neuropathies are universally recognised and cause significant morbidity. At present improving glycaemic control is the only recognised treatment. A man with type 2 diabetes presented with disabling asymmetric lower limb proximal neuropathy. Rapid clinical, functional, and electrical improvement followed treatment with intravenous immunoglobulin. The aetiology of diabetic amyotrophy rem...
متن کاملIntravenous immunoglobulin therapy for diabetic amyotrophy.
A 49-year-old woman with diabetes mellitus developed progressive weakness and atrophy of both thighs rendering her wheelchair-bound within two months. The neurological findings and electrophysiological test results were compatible with diabetic amyotrophy (DA). Immediately after intravenous immunoglobulin (IVIg) therapy (20 g x 3 days), she became able to walk with a cane. After the next course...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Ulster Medical Journal
دوره 61 شماره
صفحات -
تاریخ انتشار 1992